Global Mycoplasma Testing Market Size study, by Product & Services (Reagents & Kits, Instruments, Services), by Technique (Polymerase Chain Reaction (PCR), Elisa, Direct Assays, Indirect Assays, DNA Staining, Others), by Application (Cell Line Testing, Virus Testing, End-of-Production Cell Testing, Others), by End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Cell Banks, Others) and Regional Forecasts 2020-2026
Global Mycoplasma Testing Market is valued approximately USD 662 million in 2019 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2020-2026. Mycoplasma is referred to as the class of bacteria commonly present in cell culture. It is also known as mollicutes, these bacteria require a cell wall, which make them impervious to frequently use antibiotics, such as penicillin. Mycoplasma is easily spread via droplets throughout cell culture and can persist in dried form for months. Mycoplasma infection is complex to see with a microscope and involves specific testing, to be detected. Infection can have an acute impact on experimental work reliant on the species present. Mycoplasma organisms can affect cell growth, tumorigenicity, metabolism and response to chemotherapy. Rising research activities conducted by pharmaceutical and biotechnology companies, increased government support and funding in research activities, and growing cell culture contamination around the world are the few factors responsible for high CAGR of the market over the forecast period. For instance, in 2018, Boehringer Ingelheim, a pharmaceutical company, has announced its plans to invest almost $259 million for its novel Biologicals Development Center (BDC), to be sited as a R&D hub in Germany. Similarly, Merck KGaA is also planning to invest around $16 billion in R&D over the next five years, in addition to its yearly investment of $7 billion. Therefore, a huge amount of investments in R&D activities, is expected to drive the demand for mycoplasma testing products around the world. However, high degree of consolidation acts and stringent regulatory framework are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.
The regional analysis of global Mycoplasma Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the expanding healthcare expenditure and rising investments by the U.S. government to enhance research-based activities in biopharmaceutical industries. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to regulatory policies enacted by healthcare organizations for improving biosafety quality in the countries like China and India.
Major market player included in this report are:
Charles River Laboratories International, Inc.
Merck KGaA
Lonza Group Ltd.
Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)
Thermo Fisher Scientific Inc.
American Type Culture Collection
Biounique Testing Laboratories Inc.
Invivogen
Promocell GmbH
Biological Industries Israel Beit Haemek Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Services:
Reagents & Kits
Instruments
Services & Software
By Technique:
Polymerase Chain Reaction (PCR)
Elisa
Direct Assays
Indirect Assays
DNA Staining
Others
By Application:
Cell Line Testing
Virus Testing
End-of-Production Cell Testing
Others
By End-User:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Cell Banks
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Mycoplasma Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global Mycoplasma Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the expanding healthcare expenditure and rising investments by the U.S. government to enhance research-based activities in biopharmaceutical industries. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to regulatory policies enacted by healthcare organizations for improving biosafety quality in the countries like China and India.
Major market player included in this report are:
Charles River Laboratories International, Inc.
Merck KGaA
Lonza Group Ltd.
Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)
Thermo Fisher Scientific Inc.
American Type Culture Collection
Biounique Testing Laboratories Inc.
Invivogen
Promocell GmbH
Biological Industries Israel Beit Haemek Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Services:
Reagents & Kits
Instruments
Services & Software
By Technique:
Polymerase Chain Reaction (PCR)
Elisa
Direct Assays
Indirect Assays
DNA Staining
Others
By Application:
Cell Line Testing
Virus Testing
End-of-Production Cell Testing
Others
By End-User:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Cell Banks
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Mycoplasma Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Mycoplasma Testing Market, by Region, 2018-2026 (USD Million)
1.2.2. Mycoplasma Testing Market, by Product & Services, 2018-2026 (USD Million)
1.2.3. Mycoplasma Testing Market, by Technique, 2018-2026 (USD Million)
1.2.4. Mycoplasma Testing Market, by Application, 2018-2026 (USD Million)
1.2.5. Mycoplasma Testing Market, by End-User, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL MYCOPLASMA TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL MYCOPLASMA TESTING MARKET DYNAMICS
3.1. Mycoplasma Testing Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL MYCOPLASMA TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICES
5.1. Market Snapshot
5.2. Global Mycoplasma Testing Market by Product & Services, Performance - Potential Analysis
5.3. Global Mycoplasma Testing Market Estimates & Forecasts by Product & Services 2016-2026 (USD Million)
5.4. Mycoplasma Testing Market, Sub Segment Analysis
5.4.1. Reagents & Kits
5.4.2. Instruments
5.4.3. Services
CHAPTER 6. GLOBAL MYCOPLASMA TESTING MARKET, BY TECHNIQUE
6.1. Market Snapshot
6.2. Global Mycoplasma Testing Market by Technique, Performance - Potential Analysis
6.3. Global Mycoplasma Testing Market Estimates & Forecasts by Technique 2016-2026 (USD Million)
6.4. Mycoplasma Testing Market, Sub Segment Analysis
6.4.1. Polymerase Chain Reaction (PCR)
6.4.2. Elisa
6.4.3. Direct Assays
6.4.4. Indirect Assays
6.4.5. DNA Staining
6.4.6. Others
CHAPTER 7. GLOBAL MYCOPLASMA TESTING MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Mycoplasma Testing Market by Application, Performance - Potential Analysis
7.3. Global Mycoplasma Testing Market Estimates & Forecasts by Application 2016-2026 (USD Million)
7.4. Mycoplasma Testing Market, Sub Segment Analysis
7.4.1. Cell Line Testing
7.4.2. Virus Testing
7.4.3. End-of-Production Cell Testing
7.4.4. Others
CHAPTER 8. GLOBAL MYCOPLASMA TESTING MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Mycoplasma Testing Market by End-User, Performance - Potential Analysis
8.3. Global Mycoplasma Testing Market Estimates & Forecasts by End-User 2016-2026 (USD Million)
8.4. Mycoplasma Testing Market, Sub Segment Analysis
8.4.1. Pharmaceutical and Biotechnology Companies
8.4.2. Contract Research Organizations
8.4.3. Academic Research Institutes
8.4.4. Cell Banks
8.4.5. Others
CHAPTER 9. GLOBAL MYCOPLASMA TESTING MARKET, REGIONAL ANALYSIS
9.1. Mycoplasma Testing Market, Regional Market Snapshot
9.2. North America Mycoplasma Testing Market
9.2.1. U.S. Mycoplasma Testing Market
9.2.1.1. Product & Services breakdown estimates & forecasts, 2016-2026
9.2.1.2. Technique breakdown estimates & forecasts, 2016-2026
9.2.1.3. Application breakdown estimates & forecasts, 2016-2026
9.2.1.4. End-User breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Mycoplasma Testing Market
9.3. Europe Mycoplasma Testing Market Snapshot
9.3.1. U.K. Mycoplasma Testing Market
9.3.2. Germany Mycoplasma Testing Market
9.3.3. Rest of Europe Mycoplasma Testing Market
9.4. Asia-Pacific Mycoplasma Testing Market Snapshot
9.4.1. China Mycoplasma Testing Market
9.4.2. India Mycoplasma Testing Market
9.4.3. Japan Mycoplasma Testing Market
9.4.4. Rest of Asia Pacific Mycoplasma Testing Market
9.5. Latin America Mycoplasma Testing Market Snapshot
9.5.1. Brazil Mycoplasma Testing Market
9.5.2. Mexico Mycoplasma Testing Market
9.6. Rest of The World Mycoplasma Testing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Charles River Laboratories International, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck KGaA
10.2.3. Lonza Group Ltd.
10.2.4. Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)
10.2.5. Thermo Fisher Scientific Inc.
10.2.6. American Type Culture Collection
10.2.7. Biounique Testing Laboratories Inc.
10.2.8. Invivogen
10.2.9. Promocell GmbH
10.2.10. Biological Industries Israel Beit Haemek Ltd.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Mycoplasma Testing Market, by Region, 2018-2026 (USD Million)
1.2.2. Mycoplasma Testing Market, by Product & Services, 2018-2026 (USD Million)
1.2.3. Mycoplasma Testing Market, by Technique, 2018-2026 (USD Million)
1.2.4. Mycoplasma Testing Market, by Application, 2018-2026 (USD Million)
1.2.5. Mycoplasma Testing Market, by End-User, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL MYCOPLASMA TESTING MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL MYCOPLASMA TESTING MARKET DYNAMICS
3.1. Mycoplasma Testing Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL MYCOPLASMA TESTING MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL MYCOPLASMA TESTING MARKET, BY PRODUCT & SERVICES
5.1. Market Snapshot
5.2. Global Mycoplasma Testing Market by Product & Services, Performance - Potential Analysis
5.3. Global Mycoplasma Testing Market Estimates & Forecasts by Product & Services 2016-2026 (USD Million)
5.4. Mycoplasma Testing Market, Sub Segment Analysis
5.4.1. Reagents & Kits
5.4.2. Instruments
5.4.3. Services
CHAPTER 6. GLOBAL MYCOPLASMA TESTING MARKET, BY TECHNIQUE
6.1. Market Snapshot
6.2. Global Mycoplasma Testing Market by Technique, Performance - Potential Analysis
6.3. Global Mycoplasma Testing Market Estimates & Forecasts by Technique 2016-2026 (USD Million)
6.4. Mycoplasma Testing Market, Sub Segment Analysis
6.4.1. Polymerase Chain Reaction (PCR)
6.4.2. Elisa
6.4.3. Direct Assays
6.4.4. Indirect Assays
6.4.5. DNA Staining
6.4.6. Others
CHAPTER 7. GLOBAL MYCOPLASMA TESTING MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Mycoplasma Testing Market by Application, Performance - Potential Analysis
7.3. Global Mycoplasma Testing Market Estimates & Forecasts by Application 2016-2026 (USD Million)
7.4. Mycoplasma Testing Market, Sub Segment Analysis
7.4.1. Cell Line Testing
7.4.2. Virus Testing
7.4.3. End-of-Production Cell Testing
7.4.4. Others
CHAPTER 8. GLOBAL MYCOPLASMA TESTING MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Mycoplasma Testing Market by End-User, Performance - Potential Analysis
8.3. Global Mycoplasma Testing Market Estimates & Forecasts by End-User 2016-2026 (USD Million)
8.4. Mycoplasma Testing Market, Sub Segment Analysis
8.4.1. Pharmaceutical and Biotechnology Companies
8.4.2. Contract Research Organizations
8.4.3. Academic Research Institutes
8.4.4. Cell Banks
8.4.5. Others
CHAPTER 9. GLOBAL MYCOPLASMA TESTING MARKET, REGIONAL ANALYSIS
9.1. Mycoplasma Testing Market, Regional Market Snapshot
9.2. North America Mycoplasma Testing Market
9.2.1. U.S. Mycoplasma Testing Market
9.2.1.1. Product & Services breakdown estimates & forecasts, 2016-2026
9.2.1.2. Technique breakdown estimates & forecasts, 2016-2026
9.2.1.3. Application breakdown estimates & forecasts, 2016-2026
9.2.1.4. End-User breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Mycoplasma Testing Market
9.3. Europe Mycoplasma Testing Market Snapshot
9.3.1. U.K. Mycoplasma Testing Market
9.3.2. Germany Mycoplasma Testing Market
9.3.3. Rest of Europe Mycoplasma Testing Market
9.4. Asia-Pacific Mycoplasma Testing Market Snapshot
9.4.1. China Mycoplasma Testing Market
9.4.2. India Mycoplasma Testing Market
9.4.3. Japan Mycoplasma Testing Market
9.4.4. Rest of Asia Pacific Mycoplasma Testing Market
9.5. Latin America Mycoplasma Testing Market Snapshot
9.5.1. Brazil Mycoplasma Testing Market
9.5.2. Mexico Mycoplasma Testing Market
9.6. Rest of The World Mycoplasma Testing Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Charles River Laboratories International, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck KGaA
10.2.3. Lonza Group Ltd.
10.2.4. Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)
10.2.5. Thermo Fisher Scientific Inc.
10.2.6. American Type Culture Collection
10.2.7. Biounique Testing Laboratories Inc.
10.2.8. Invivogen
10.2.9. Promocell GmbH
10.2.10. Biological Industries Israel Beit Haemek Ltd.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL MYCOPLASMA TESTING MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL MYCOPLASMA TESTING MARKET
TABLE 3. GLOBAL MYCOPLASMA TESTING MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY PRODUCT & SERVICES 2016-2026 (USD MILLION)
TABLE 8. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY TECHNIQUE 2016-2026 (USD MILLION)
TABLE 9. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
TABLE 10. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
TABLE 11. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 24. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 27. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 30. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 33. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 36. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 39. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 40. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 43. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 46. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 49. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 51. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 52. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 54. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 55. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 57. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 58. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 59. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL MYCOPLASMA TESTING MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL MYCOPLASMA TESTING MARKET
TABLE 3. GLOBAL MYCOPLASMA TESTING MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY PRODUCT & SERVICES 2016-2026 (USD MILLION)
TABLE 8. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY TECHNIQUE 2016-2026 (USD MILLION)
TABLE 9. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
TABLE 10. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
TABLE 11. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 24. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 27. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 30. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 33. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 36. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 39. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 40. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 43. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 46. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 49. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 51. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 52. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 54. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 55. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 57. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 58. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 59. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
LIST OF FIGURES
FIG 1. GLOBAL MYCOPLASMA TESTING MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL MYCOPLASMA TESTING MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL MYCOPLASMA TESTING MARKET, KEY TRENDS 2019
FIG 5. GLOBAL MYCOPLASMA TESTING MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL MYCOPLASMA TESTING MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL MYCOPLASMA TESTING MARKET, PEST ANALYSIS
FIG 8. GLOBAL MYCOPLASMA TESTING MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 10. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 11. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 12. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 13. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 14. GLOBAL MYCOPLASMA TESTING MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA MYCOPLASMA TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 16. EUROPE MYCOPLASMA TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 17. ASIA PACIFIC MYCOPLASMA TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 18. LATIN AMERICA MYCOPLASMA TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 19. GLOBAL MYCOPLASMA TESTING MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
COMPANIES MENTIONED
Charles River Laboratories International, Inc.
Merck KGaA
Lonza Group Ltd.
Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)
Thermo Fisher Scientific Inc.
American Type Culture Collection
Biounique Testing Laboratories Inc.
Invivogen
Promocell GmbH
Biological Industries Israel Beit Haemek Ltd.
FIG 1. GLOBAL MYCOPLASMA TESTING MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL MYCOPLASMA TESTING MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL MYCOPLASMA TESTING MARKET, KEY TRENDS 2019
FIG 5. GLOBAL MYCOPLASMA TESTING MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL MYCOPLASMA TESTING MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL MYCOPLASMA TESTING MARKET, PEST ANALYSIS
FIG 8. GLOBAL MYCOPLASMA TESTING MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 10. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 11. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 12. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 13. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 14. GLOBAL MYCOPLASMA TESTING MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA MYCOPLASMA TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 16. EUROPE MYCOPLASMA TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 17. ASIA PACIFIC MYCOPLASMA TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 18. LATIN AMERICA MYCOPLASMA TESTING MARKET 2016 & 2026 (USD MILLION)
FIG 19. GLOBAL MYCOPLASMA TESTING MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
COMPANIES MENTIONED
Charles River Laboratories International, Inc.
Merck KGaA
Lonza Group Ltd.
Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)
Thermo Fisher Scientific Inc.
American Type Culture Collection
Biounique Testing Laboratories Inc.
Invivogen
Promocell GmbH
Biological Industries Israel Beit Haemek Ltd.
